Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an announcement.
Proteomics International Laboratories Ltd announced the appointment of Ms. Vicki Robinson as an independent non-executive director. With over 20 years of experience in executive and governance roles, Ms. Robinson is expected to enhance the company’s strategic and decision-making capabilities. Her appointment comes at a crucial time as Proteomics International rolls out its leading diagnostic products, which have the potential to transform the management of chronic conditions such as diabetic kidney disease, endometriosis, and esophageal cancer.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, the large-scale study of proteins, aiming to improve disease treatment through innovative diagnostic tools.
Average Trading Volume: 363,682
Technical Sentiment Signal: Sell
Current Market Cap: A$61.38M
Learn more about PIQ stock on TipRanks’ Stock Analysis page.